Regulation of Nrf2 by phosphorylation: Consequences for biological function and therapeutic implications

The transcription factor nuclear factor erythroid-derived 2-like 2 (NRF2) participates in the activation of the antioxidant cytoprotective pathway and other important physiological processes to maintain cellular homeostasis. The dysregulation of NRF2 activity plays a role in various diseases, such a...

Full description

Saved in:
Bibliographic Details
Published inFree radical biology & medicine Vol. 168; pp. 129 - 141
Main Authors Liu, Tian, Lv, Yi-Fei, Zhao, Jing-Long, You, Qi-Dong, Jiang, Zheng-Yu
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 20.05.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The transcription factor nuclear factor erythroid-derived 2-like 2 (NRF2) participates in the activation of the antioxidant cytoprotective pathway and other important physiological processes to maintain cellular homeostasis. The dysregulation of NRF2 activity plays a role in various diseases, such as cardiovascular diseases, neurodegenerative diseases, and cancer. Thus, NRF2 activity is tightly regulated through multiple mechanisms, among which phosphorylation by kinases is critical in the posttranslational regulation of NRF2. For instance, PKC, casein kinase 2, and AMP-activated kinase positively, while GSK-3 negatively regulates NRF2 activity through phosphorylation of different sites. Here, we provide an overview of the phosphorylation regulation pattern of NRF2 and discuss the therapeutic potential of interventions targeting NRF2 phosphorylation. [Display omitted] •Protein kinases phosphorylate Nrf2 to modulate its stability and/or activity.•Phosphorylation regulation of NRF2 bridges NRF2 activity to a series of biological events.•Targeting NRF2 phosphorylation regulation shows therapeutic potential for multiple inflammation-related diseases.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:0891-5849
1873-4596
1873-4596
DOI:10.1016/j.freeradbiomed.2021.03.034